Research Studies: Other Related Studies

DBSA does not endorse nor recommend any particular research study. Patients should discuss all options with their health care providers and family members before beginning any study.

Many people think that participating in a research study means they will get better treatment for their illness. While this may be true, it's important to remember that a research study is conducted for research purposes—it does not ensure better or safer treatment.

Taking part in a study does not guarantee individual benefits to the participant in the form of newer or safer treatment. The contribution made participating in a research study is to science first and to the patient second.

DBSA, its advisors, and its consultants do not endorse or recommend the use of any specific treatment or medication. For advice about specific treatment or medication, patients should consult their physicians and/or mental health professionals.


Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder (NERF) (Cincinnati, Ohio)

The purpose of this research study is to investigate brain changes in adolescents who are currently experiencing Attention Deficit Hyperactive Disorder (ADHD) symptoms and have a family history of bipolar disorder. Eligible participants will be randomized to mixed amphetamine salts or placebo for 12-week treatment. Study procedures will include MRI scans, blood draws and ECGs. All study procedures and medications will be provided at no cost to the participant. Participants may be compensated up to $280 for their participation.

Participants will be restricted from taking specific medications during the study, no other treatments will be restricted. Participants have a 50% chance of being randomized to the placebo group. This will last for the entirety of the study, up to 12 weeks, or until participant withdraws from the study.

Contact
Leah Fleischer
513-558-3674
Fleisclm@ucmail.uc.edu

Deadline for Enrollment: 01/01/2020